Typically, the eligibility criteria for GLP-1 medication are: a body mass index (BMI) score of 30 or over a BMI of 27 or over and a weight-related health condition The weight-related health conditions can include those such as diabetes, high cholesterol, or high blood pressure
Demand remained particularly strong for berberine, chromium, fiber, and probiotic formulations targeting appetite control, insulin sensitivity, and sustained energy management
Whats Inside: Electrolyte Fluid (1000 mL Hydration Fluid) Additional supportive options may be available when clinically appropriate
Int J Mol Sci, 18(11) Volmering E, Niehusmann P, Peeva V et al (2016) Neuropathological signs of inflammation correlate with mitochondrial DNA deletions in mesial temporal lobe epilepsy [J]
(2025) Figure 2: Created in BioRender